References

1. Levine MN. Hemorrhagic complications of anticoagulant treatment. Chest. 2001; 119 (1 suppl): 108-121. PubMed | Google Scholar


2. Trompetas V, Yettimis E, Varsamidakis N, Courcoutsakis N, Kalokairinos E. Endoscopic diagnosis and conservative management of an intramural sigmoid haematoma complicating anticoagulant therapy. Acta Gastroenterol Belg. 2007; 70(3): 313-315. PubMed | Google Scholar


3. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996; 348 (9025): 423-428. PubMed | Google Scholar


4. Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Samuel Z. Major bleeding complication in a Specialized Anticoagulation Service. American journal of cardiology. 2005; 96(4): 595-598. PubMed | Google Scholar


5. Cannegieter SC, Rosendaal FR, Wintzen AR, Van Der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Eng J Med. 1995; 333: 11-17. PubMed | Google Scholar


6. Chtata H, Alahyane A, Yaka M, Oukabli M, Taberkant M, Elkirrat A. Hématome spontané du mésosigmoïde: une complication exceptionnelle des anticoagulants oraux au long cours. Gastroentérologie Clinique et Biologique. 2009; 33(6-7): 92-96. PubMed | Google Scholar


7. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment. Chest. 2008; 133(6 suppl): 257-298. PubMed | Google Scholar


8. Gouezec H, Jego P, Pierre-Bétrémieux C, Stanislas-Nimubona D, Isabelle G. Les indications des produits sanguins labiles et la physiologie de la transfusion en médecine. Transfusion clinique et biologique. 2005; 12(2): 169- 176. PubMed | Google Scholar


9. Hirsh J. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range; The fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1998; 114 ( 5 suppl):445S-469S. PubMed | Google Scholar